Drug intelligence / Profile preview

Ultimate Omega

Development stage: Phase 1
Lead developer: Nordic Naturals
Modality: Small Molecules
Administration: Oral

Overview

Ultimate Omega is a high-potency omega-3 dietary supplement developed by Nordic Naturals. It features a concentrated blend of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) derived from fish oil, provided in the triglyceride form for optimal absorption. The supplement is widely utilized for supporting cardiovascular health, cognitive function, and immune system balance. In clinical research, such as trial NCT05924139, Ultimate Omega has been investigated for its potential to enhance athletic performance, improve body composition (lean vs. fat mass), and reduce exercise-induced muscle soreness by modulating inflammatory pathways and supporting muscle recovery processes.

Brand names: Ultimate Omega
Other names: Nordic Naturals Ultimate Omega

Targets

COXPPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Ultimate Omega.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultimate Omega.